Eribulin versus dacarbazine in previously treated patients with advanced liposarcoma or leiomyosarcoma: a randomised, open-label, multicentre, phase 3 trial

Autor: Schöffski, Patrick, Chawla, Sant, Maki, Robert G, Italiano, Antoine, Gelderblom, Hans, Choy, Edwin, Grignani, Giovanni, Camargo, Veridiana, Bauer, Sebastian, Rha, Sun Young, Blay, Jean-Yves, Hohenberger, Peter, D'Adamo, David, Guo, Matthew, Chmielowski, Bartosz, Le Cesne, Axel, Demetri, George D, Patel, Shreyaskumar R
Zdroj: In The Lancet 16-22 April 2016 387(10028):1629-1637
Databáze: ScienceDirect